Dose‐Dependent, Therapeutic Potential of Angiotensin‐(1–7) for the Treatment of Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

Dose‐Dependent, Therapeutic Potential of Angiotensin‐(1–7) for the Treatment of Pulmonary Arterial Hypertension

Published:2015-12 Issue:4 Volume:5 Page:649-657
ISSN:2045-8940
Container-title:Pulmonary Circulation
language:en
Short-container-title:Pulm. circ.

Author:

Breitling Siegfried¹²,Krauszman Adrienn¹³,Parihar Richa¹,Walther Thomas⁴,Friedberg Mark K.⁵,Kuebler Wolfgang M.¹³⁶⁷

Affiliation:

1. Keenan Research Centre for Biomedical ScienceSt. Michael's HospitalTorontoOntarioCanada

2. Institute for Chemistry and BiochemistryFreie Universität BerlinBerlinGermany

3. Institute of PhysiologyCharité‐Universitätsmedizin BerlinBerlinGermany

4. Department of Pharmacology and TherapeuticsSchool of MedicineSchool of PharmacyUniversity College CorkCorkIreland

5. Labatt Family Heart CenterDivision of Cardiology and Cardiovascular SurgeryHospital for Sick Children and University of TorontoTorontoOntarioCanada

6. Departments of Surgery and PhysiologyUniversity of TorontoTorontoOntarioCanada

7. German Heart Institute BerlinBerlinGermany

Funder

Tarix Pharmaceuticals

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1086/683696

Reference35 articles.

1. Updated clinical classification of pulmonary hypertension;Simonneau G;J Am Coll Cardiol,2009

2. The endothelin system in pulmonary arterial hypertension;Galiè N;Cardiovasc Res,2004

3. Role of nitric oxide in the pathogenesis of chronic pulmonary hypertension;Hampl V;Physiol Rev,2000

4. Therapeutic targets in pulmonary arterial hypertension;Rhodes CJ;Pharmacol Ther,2009

5. Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation;Thenappan T;Eur Respir J,2010

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Co-activation of Mas and pGCA receptors suppresses Endothelin-1-induced endothelial dysfunction via nitric oxide/cGMP system;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-04

2. Angiotensin 1–7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart—The signaling mechanism;Fundamental & Clinical Pharmacology;2024-02-04

3. Angiotensin-Converting Enzyme 2 (ACE2) Signaling in Pulmonary Arterial Hypertension: Underpinning Mechanisms and Potential Targeting Strategies;International Journal of Molecular Sciences;2023-12-13

4. Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats;International Journal of Molecular Sciences;2023-04-19

5. Novel and emerging therapies in pulmonary arterial hypertension;Frontiers in Drug Discovery;2022-12-15